HRT FINANCIAL LP

Holdings History for MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (MLTX)

Symbol: MLTX on Nasdaq
Investment type: Equity / Class A ordinary share, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.03%	+0.02%	$8,381,000	635,901	+492,626	+344%	$13.18	Q4 2025
30 Sep 2025	0%	+0%	$1,027,000	143,275	+143,275	NEW	$7.17	Q3 2025
31 Dec 2024		-0%	$0	0	-13,592	-100%	$18.77	Q4 2024
30 Sep 2024	0%	+0%	$685,000	13,592	+13,592	NEW	$50.40	Q3 2024
30 Jun 2024		-0.01%	$0	0	-31,941	-100%	$18.77	Q2 2024
31 Mar 2024	0.01%	+0.01%	$1,604,000	31,941	+16,650	+109%	$50.22	Q1 2024
31 Dec 2023	0.01%	+0.01%	$923,000	15,291	+15,291	NEW	$60.36	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.